Through yeast two-hybrid expression screening of a human breast cancer library, MAL2 was identified as the molecular chaperone of tumor protein D52-like protein (TPD52) and MUC1 (Fanayan et al., 2009; Li et al., 2017). This evidence concerns the gene MAL2 and breast carcinoma.